Evolent Health (Germany) Today
9EH Stock | EUR 12.20 0.40 3.17% |
Performance0 of 100
| Odds Of DistressLess than 23
|
Evolent Health is trading at 12.20 as of the 1st of December 2024. This is a 3.17 percent decrease since the beginning of the trading day. The stock's lowest day price was 12.2. Evolent Health has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Evolent Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. EVOLENT HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. The company has 111.05 M outstanding shares. More on Evolent Health
Moving against Evolent Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Evolent Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Evolent Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Evolent Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO CoFounder | Seth Blackley |
Thematic Idea | Health Management (View all Themes) |
Business Concentration | Health Management, Health Information Services, Technology (View all Sectors) |
Evolent Health (9EH) is traded on Frankfurt Exchange in Germany and employs 4,000 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.69 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Evolent Health's market, we take the total number of its shares issued and multiply it by Evolent Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Evolent Health classifies itself under Technology sector and is part of Health Information Services industry. The entity has 111.05 M outstanding shares.
Evolent Health has accumulated about 172.86 M in cash with (11.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.11.
Check Evolent Health Probability Of Bankruptcy
Ownership AllocationEvolent Health holds a total of 111.05 Million outstanding shares. The majority of Evolent Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Evolent Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Evolent Health. Please pay attention to any change in the institutional holdings of Evolent Health as this could imply that something significant has changed or is about to change at the company. Also note that almost eight million one hundred twenty-nine thousand six invesors are currently shorting Evolent Health expressing very little confidence in its future performance.
Check Evolent Ownership Details
Evolent Health Risk Profiles
Although Evolent Health's alpha and beta are two of the key measurements used to evaluate Evolent Health's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 3.36 | |||
Standard Deviation | 6.01 | |||
Variance | 36.07 | |||
Risk Adjusted Performance | (0.13) |
Evolent Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Evolent Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
All Next | Launch Module |
Evolent Health Corporate Management
Elected by the shareholders, the Evolent Health's board of directors comprises two types of representatives: Evolent Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Evolent. The board's role is to monitor Evolent Health's management team and ensure that shareholders' interests are well served. Evolent Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Evolent Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jonathan JD | Gen Officer | Profile | |
Aammaad Shams | Chief Controller | Profile | |
Jessica Somers | Sr Devel | Profile | |
Seth Frank | VP Relations | Profile | |
MAAA FSA | Chief Officer | Profile | |
John Johnson | Chief Officer | Profile |
Additional Information and Resources on Investing in Evolent Stock
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.